Search

Your search keyword '"Perez-Diaz-Del-Campo, Nuria"' showing total 27 results
Start Over Author "Perez-Diaz-Del-Campo, Nuria"
27 results on '"Perez-Diaz-Del-Campo, Nuria"'

2. Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease

Author

Rosso, Chiara, Caviglia, Gian Paolo, Birolo, Giovanni, Armandi, Angelo, Pennisi, Grazia, Pelusi, Serena, Younes, Ramy, Liguori, Antonio, Perez-Diaz-del-Campo, Nuria, Nicolosi, Aurora, Govaere, Olivier, Castelnuovo, Gabriele, Olivero, Antonella, Abate, Maria Lorena, Ribaldone, Davide Giuseppe, Fariselli, Piero, Valenti, Luca, Miele, Luca, Petta, Salvatore, Romero-Gomez, Manuel, Anstee, Quentin M., and Bugianesi, Elisabetta

Published
2023
Full Text
View/download PDF

6. Potential application of the simulator of the human intestinal microbial ecosystem in metabolic dysfunction-associated steatotic liver disease.

Author

CASTELNUOVO, Gabriele, PEREZ-DIAZ-DEL-CAMPO, Nuria, DUBOIS, Simon, FRANCIOSA, Irene, and BUGIANESI, Elisabetta

Subjects
*SMALL intestine, *GASTROINTESTINAL diseases, *LIVER diseases, *GUT microbiome, *INSULIN resistance, *GASTROINTESTINAL system
Abstract

INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a growing global health concern, as it has become the most prevalent chronic liver condition worldwide, currently estimated to affect up to 38% of the adult population. EVIDENCE ACQUISITION: MASLD is a complex disease impacting multiple systems, where systemic insulin resistance and related metabolic dysfunction play a pathogenic role in its development and progression of the disease. Despite its prevalence, MASLD is frequently under-recognized due to the lack of reliable non-invasive biomarkers for accurate diagnosis and staging, and effective treatments remain elusive. EVIDENCE SYNTHESIS: Growing evidence suggests that the gut microbiome significantly influences the occurrence and progression of MASLD due to gut dysbiosis. The Simulator of the Human Intestinal Microbial Ecosystem® (SHIME®) is a sophisticated gut models that mimics the entire gastrointestinal tract, incorporating stomach, small intestine, and different colon regions, each characterized by distinct physiology, anatomy, and microbial community. CONCLUSIONS: The SHIME® model emerges as a valuable tool for exploring therapeutic approaches based on gut microbiota management. This gastrointestinal simulator offers a unique platform for studying the complex interactions within the gut-liver axis. The ongoing development of this technology is expected to yield further insights into effective strategies for managing MASLD, improving patient outcomes through targeted microbiota interventions. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Author

Castelnuovo, Gabriele, Perez-Diaz-del-Campo, Nuria, Rosso, Chiara, Armandi, Angelo, Caviglia, Gian Paolo, and Bugianesi, Elisabetta

Abstract

Plant-based diets (PBDs) are gaining attention as a sustainable and health-conscious alternative for managing various chronic conditions, including metabolic dysfunction-associated steatotic liver disease (MASLD). In the absence of pharmacological treatments, exploring the potential of lifestyle modifications to improve biochemical and pathological outcomes becomes crucial. The adoption of PBDs has demonstrated beneficial effects such as weight control, increased metabolic health and improved coexisting diseases. Nonetheless, challenges persist, including adherence difficulties, ensuring nutritional adequacy, and addressing potential deficiencies. The aim of this review is to provide a comprehensive overview of the impact of PBDs on MASLD, emphasizing the need for tailored dietary interventions with professional support to optimize their effectiveness in preventing and treating metabolic diseases. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with non-alcoholic fatty liver disease

Author

Rosso, Chiara, primary, Caviglia, Gian Paolo, additional, Birolo, Giovanni, additional, Armandi, Angelo, additional, Pennisi, Grazia, additional, Pelusi, Serena, additional, Younes, Ramy, additional, Liguori, Antonio, additional, Perez-Diaz-del-Campo, Nuria, additional, Nicolosi, Aurora, additional, Govaere, Olivier, additional, Castelnuovo, Gabriele, additional, Olivero, Antonella, additional, Abate, Maria Lorena, additional, Ribaldone, Davide Giuseppe, additional, Fariselli, Piero, additional, Valenti, Luca, additional, Miele, Luca, additional, Petta, Salvatore, additional, Romero-Gomez, Manuel, additional, Anstee, Quentin M., additional, and Bugianesi, Elisabetta, additional

Published
2023
Full Text
View/download PDF

14. Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease

Author

Armandi, Angelo, primary, Caviglia, Gian Paolo, additional, Abdulle, Amina, additional, Rosso, Chiara, additional, Gjini, Kamela, additional, Castelnuovo, Gabriele, additional, Guariglia, Marta, additional, Perez Diaz del Campo, Nuria, additional, D’Amato, Daphne, additional, Ribaldone, Davide Giuseppe, additional, Saracco, Giorgio Maria, additional, and Bugianesi, Elisabetta, additional

Published
2023
Full Text
View/download PDF

16. The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease

Author

Armandi, Angelo, primary, Colombo, Giorgia, additional, Rosso, Chiara, additional, Caviglia, Gian Paolo, additional, Olivero, Antonella, additional, Abate, Maria Lorena, additional, Guariglia, Marta, additional, Perez Diaz del Campo, Nuria, additional, Castelnuovo, Gabriele, additional, Ribaldone, Davide Giuseppe, additional, Saracco, Giorgio Maria, additional, Genazzani, Armando A., additional, and Bugianesi, Elisabetta, additional

Published
2023
Full Text
View/download PDF

17. A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers

Author

PEREZ-DIAZ-DEL-CAMPO, Nuria, primary, RIEZU-BOJ, Jose I., additional, MARIN-ALEJANDRE, Bertha A., additional, MONREAL, J. Ignacio, additional, ELORZ, Mariana, additional, HERRERO, José I., additional, BENITO-BOILLOS, Alberto, additional, MILAGRO, Fermín I., additional, BUGIANESI, Elisabetta, additional, TUR, Josep A., additional, MARTINEZ, J. Alfredo, additional, ABETE, Itziar, additional, and ZULET, M. Angeles, additional

Published
2022
Full Text
View/download PDF

19. Prevalence of Multiple Sclerosis in Patients with Inflammatory Bowel Disease.

Author

Perez-Diaz-del-Campo, Nuria, Caviglia, Gian Paolo, Piana, Giorgia La, Vernero, Marta, Schillaci, Valentina, Armandi, Angelo, Stalla, Francesco, Pitoni, Demis, Bugianesi, Elisabetta, Ciancio, Alessia, Cavalla, Paola, and Ribaldone, Davide Giuseppe

Subjects
MULTIPLE sclerosis risk factors, MULTIPLE sclerosis, CROHN'S disease, ULCERATIVE colitis, INFLAMMATORY bowel diseases, LIFE expectancy, RETROSPECTIVE studies, RISK assessment, SEX distribution, COMPARATIVE studies, TREATMENT effectiveness, PSYCHOLOGY of women, DESCRIPTIVE statistics, MESALAMINE
Abstract

Being two immune-mediated diseases (IMIDs), the association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) is plausible, but data in the literature are conflicting. The aim of our study was to evaluate the possible association between IBD and MS in a cohort of patients with IBD. In a retrospective study, we examined the medical records of 5739 patients with a confirmed diagnosis of IBD followed in our clinic between 1978 and 2022. Among these patients, we identified 14 with MS, with a prevalence of 0.24%. The reported prevalence of MS in the general population in Northern Italy in 2021 was 0.18% (p = 0.24). For each of the patients with MS identified, more than ten patients without MS were analyzed. The 14 MS cases were then compared with 342 controls. From the 14 patients with MS, 12 (85.7%) were female and 2 (14.3%) were male, while in the control group, 158 (46.2%) were female and 184 (53.8%) were male (p = 0.004). As for therapy, significant differences were found in mesalazine (5 (41.7%) cases vs. 317 (92.7%) controls, p < 0.0001) and anti-TNF treatment (0% cases vs. 26.6% controls, p = 0.03, respectively) at the time of MS diagnosis. Moreover, a Kaplan–Meier curve analysis showed that the 20-year survival probability was 98.4% for patients with IBD, while for patients diagnosed with MS and IBD it was 82.1% (p = 0.02). In conclusion, patients with IBD have a similar risk of developing MS compared to the general population, but female sex appears to increase the risk. Indeed, life expectancy at 20 years for patients with IBD and MS is lower than for patients with IBD alone. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

20. Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.

Author

Castelnuovo, Gabriele, Perez-Diaz-del-Campo, Nuria, Rosso, Chiara, Guariglia, Marta, Armandi, Angelo, Nicolosi, Aurora, Caviglia, Gian Paolo, and Bugianesi, Elisabetta

Abstract

Late chronotype, the individual's aptitude to perform daily activities late in the day, has been associated with low adherence to the Mediterranean diet (MedDiet) and metabolic syndrome. The aim of this work was to investigate the potential association of chronotype and adherence to the MedDiet with the liver fibrosis risk in patients with non-alcoholic fatty liver disease (NAFLD). Liver stiffness was assessed in 126 patients by FibroScan®530. Significant (F ≥ 2) and advanced (F ≥ 3) hepatic fibrosis were defined according to liver stiffness values ≥7.1 kPa and ≥8.8 kPa, respectively. Chronotype (MSFsc) was defined by the Munich Chronotype Questionnaire, and adherence to the MedDiet was defined by the Mediterranean diet score (MDS). Overall, the median age was 55 (46–63) years, and 57.9% of participants were male. The principal comorbidities were type-2 diabetes mellitus (T2DM) (26.1%), arterial hypertension (53.1%), dyslipidaemia (63.4%), obstructive sleep apnoea (5.5%) and depression (5.5%). Most subjects (65.0%) had intermediate + late chronotype and showed higher mid-sleep on workdays (p < 0.001) and on work-free days (p < 0.001) compared to those with early chronotype. In the logistic regression model, intermediate + late chronotype (p = 0.024), MDS (p = 0.019) and T2DM (p = 0.004) were found to be significantly and independently associated with the risk of both F ≥ 2 And F ≥ 3. We observed that the intermediate + late chronotype and low adherence to the MedDiet were associated with both significant and advanced liver fibrosis in patients with NAFLD. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

21. Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis

Author

Micó, Víctor, primary, San-Cristobal, Rodrigo, additional, Martín, Roberto, additional, Martínez-González, Miguel Ángel, additional, Salas-Salvadó, Jordi, additional, Corella, Dolores, additional, Fitó, Montserrat, additional, Alonso-Gómez, Ángel M., additional, Wärnberg, Julia, additional, Vioque, Jesús, additional, Romaguera, Dora, additional, López-Miranda, José, additional, Estruch, Ramon, additional, Tinahones, Francisco J., additional, Lapetra, José, additional, Serra-Majem, J. Luís, additional, Bueno-Cavanillas, Aurora, additional, Tur, Josep A., additional, Martín Sánchez, Vicente, additional, Pintó, Xavier, additional, Delgado-Rodríguez, Miguel, additional, Matía-Martín, Pilar, additional, Vidal, Josep, additional, Vázquez, Clotilde, additional, García-Arellano, Ana, additional, Pertusa-Martinez, Salvador, additional, Chaplin, Alice, additional, Garcia-Rios, Antonio, additional, Muñoz Bravo, Carlos, additional, Schröder, Helmut, additional, Babio, Nancy, additional, Sorli, Jose V., additional, Gonzalez, Jose I., additional, Martinez-Urbistondo, Diego, additional, Toledo, Estefania, additional, Bullón, Vanessa, additional, Ruiz-Canela, Miguel, additional, Portillo, María Puy-, additional, Macías-González, Manuel, additional, Perez-Diaz-del-Campo, Nuria, additional, García-Gavilán, Jesús, additional, Daimiel, Lidia, additional, and Martínez, J. Alfredo, additional

Published
2022
Full Text
View/download PDF

22. Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events

Author

Martinez-Urbistondo, Diego, primary, D’Avola, Delia, additional, Navarro-González, David, additional, Sanchez-Iñigo, Laura, additional, Fernandez-Montero, Alejandro, additional, Perez-Diaz-del-Campo, Nuria, additional, Bugianesi, Elisabetta, additional, Martinez, Jose Alfredo, additional, and Pastrana, Juan Carlos, additional

Published
2022
Full Text
View/download PDF

24. Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study

Author

Perez-Diaz-del-Campo, Nuria, primary, Riezu-Boj, Jose I., additional, Marin-Alejandre, Bertha Araceli, additional, Monreal, J. Ignacio, additional, Elorz, Mariana, additional, Herrero, José Ignacio, additional, Benito-Boillos, Alberto, additional, Milagro, Fermín I., additional, Tur, Josep A., additional, Abete, Itziar, additional, Zulet, M. Angeles, additional, and Martinez, J. Alfredo, additional

Published
2021
Full Text
View/download PDF

25. Effects of two personalized dietary strategies during a 2‐year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial

Author

Marin‐Alejandre, Bertha A., primary, Cantero, Irene, additional, Perez‐Diaz‐del‐Campo, Nuria, additional, Monreal, Jose I., additional, Elorz, Mariana, additional, Herrero, Jose I., additional, Benito‐Boillos, Alberto, additional, Quiroga, Jorge, additional, Martinez‐Echeverria, Ana, additional, Uriz‐Otano, Juan I., additional, Huarte‐Muniesa, Maria P., additional, Tur, Josep A., additional, Martinez, Jose A., additional, Abete, Itziar, additional, and Zulet, Maria A., additional

Published
2021
Full Text
View/download PDF

26. Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study

Author

Galarregui, Cristina, primary, Marin-Alejandre, Bertha Araceli, additional, Perez-Diaz-Del-Campo, Nuria, additional, Cantero, Irene, additional, Monreal, J. Ignacio, additional, Elorz, Mariana, additional, Benito-Boillos, Alberto, additional, Herrero, José Ignacio, additional, Tur, Josep A., additional, Martínez, J. Alfredo, additional, Zulet, M. Angeles, additional, and Abete, Itziar, additional

Published
2020
Full Text
View/download PDF

27. Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease

Author

Perez-Diaz-del-Campo, Nuria, primary, Abete, Itziar, additional, Cantero, Irene, additional, Marin-Alejandre, Bertha Araceli, additional, Monreal, J. Ignacio, additional, Elorz, Mariana, additional, Herrero, José Ignacio, additional, Benito-Boillos, Alberto, additional, Riezu-Boj, Jose I., additional, Milagro, Fermín I., additional, Tur, Josep A., additional, Martinez, J. Alfredo, additional, and Zulet, M. Angeles, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results